Search research articles
Contact Us
Filters
Showing results (181-190 of 188) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 188 results.
Cancer Immunology, Immunotherapy : CII
|
June 1, 1997
Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability
F Belli, F Arienti, J Sulé-Suso, et al.
The New England Journal of Medicine
|
September 22, 1977
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs
U Veronesi, J Adamus, D C Bandiera, et al.
Tumori
|
June 30, 1980
Stage I melanoma of the limbs. Immediate versus delayed node dissection
U Veronesi, J Adamus, D C Bandiera, et al.
Cancer
|
June 1, 1982
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities
U Veronesi, J Adamus, D C Bandiera, et al.
Cancer
|
March 16, 2000
A new American Joint Committee on Cancer staging system for cutaneous melanoma
C M Balch, A C Buzaid, M B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2001
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system
C M Balch, S J Soong, J E Gershenwald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2001
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
C M Balch, A C Buzaid, S J Soong, et al.
The New England Journal of Medicine
|
October 7, 1982
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma
U Veronesi, J Adamus, C Aubert, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 188) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 188 results.
Cancer Immunology, Immunotherapy : CII
|
June 1, 1997
Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability
F Belli, F Arienti, J Sulé-Suso, et al.
The New England Journal of Medicine
|
September 22, 1977
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs
U Veronesi, J Adamus, D C Bandiera, et al.
Tumori
|
June 30, 1980
Stage I melanoma of the limbs. Immediate versus delayed node dissection
U Veronesi, J Adamus, D C Bandiera, et al.
Cancer
|
June 1, 1982
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities
U Veronesi, J Adamus, D C Bandiera, et al.
Cancer
|
March 16, 2000
A new American Joint Committee on Cancer staging system for cutaneous melanoma
C M Balch, A C Buzaid, M B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2001
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system
C M Balch, S J Soong, J E Gershenwald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2001
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
C M Balch, A C Buzaid, S J Soong, et al.
The New England Journal of Medicine
|
October 7, 1982
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma
U Veronesi, J Adamus, C Aubert, et al.
Page
of 19